Major pharmaceutical companies continually research and develop new medications and treatments, which must be shown to be safe and effective before the FDA ( Food and Drug Administration) approves them and doctors can prescribe them to patients. Through prostate cancer clinical trials, researchers test the effects of new medications on a group of volunteers with prostate cancer. Following a strict protocol and using carefully controlled conditions, researchers evaluate the investigational drugs under development and measure the ability of the new drug to treat prostate cancer, its safety, and any possible side effects.
Some patients with prostate cancer are reluctant to take part in clinical trials for fear of getting no treatment at all for their prostate cancer. This is simply not true. Patients with prostate cancer who participate in prostate cancer clinical trials receive the most effective therapy available for their condition -- or they may receive prostate cancer treatments that are being evaluated for future use. These prostate cancer drugs may be even more effective than the current prostate cancer treatment.
Like other forms of cancer, the prognosis for prostate cancer depends on how far the cancer has spread at the time it’s diagnosed. Doctors use a system of classification called staging to describe prostate cancer’s local extent and evidence of spread.
Prostate cancer stages can be complex and difficult to understand. WebMD takes a look at prostate cancer stages and what they mean to you.
This web site, developed by the nonprofit Coalition of Cancer Cooperative Groups, is an unbiased cancer clinical trial matching and navigation service that enables patients to search for cancer trials based on disease and location.